Cargando…
Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites
Aims: The current study investigates the role of diet in mediating the gut microbiome-cardiovascular association which has not yet been explored in humans. Methods and Results: Using a two-arm dietary intervention study in healthy participants (N = 70), we assessed the effects of omega-3 and fibre s...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319029/ https://www.ncbi.nlm.nih.gov/pubmed/34336953 http://dx.doi.org/10.3389/fcvm.2021.691564 |
_version_ | 1783730377948397568 |
---|---|
author | Vijay, Amrita Astbury, Stuart Panayiotis, Louca Marques, Francine Z. Spector, Tim D. Menni, Cristina Valdes, Ana M. |
author_facet | Vijay, Amrita Astbury, Stuart Panayiotis, Louca Marques, Francine Z. Spector, Tim D. Menni, Cristina Valdes, Ana M. |
author_sort | Vijay, Amrita |
collection | PubMed |
description | Aims: The current study investigates the role of diet in mediating the gut microbiome-cardiovascular association which has not yet been explored in humans. Methods and Results: Using a two-arm dietary intervention study in healthy participants (N = 70), we assessed the effects of omega-3 and fibre supplementation on gut microbiome composition and short-chain fatty acid (SCFA) production. We then investigated how changes in gut microbiome composition correlated with changes in traditional cardiovascular risk factors (cholesterol, triglycerides, blood pressure), cytokines, and novel validated markers such as GlycA and ceramides, previously linked to CVD incidence and mortality. Both interventions resulted in significant drops in blood pressure, cholesterol, proinflammatory cytokines, GlycA and ceramides (all P < 0.05). Decreases in the atherogenic low-density lipoprotein triglyceride fraction, in total serum cholesterol were correlated with increases in butyric acid-production [β(SE) = −0.58 (0.06), P < 0.001; −0.53 (0.04), P < 0.001] and nominally associated with increases in some butyrogenic bacteria. Drops in GlycA were linked to increases in Bifidobacterium [β(SE) = −0.32 (0.04), P = 0.02] and other SCFAs including acetic acid [β(SE) = −0.28 (0.04), P = 0.02] and propionic acid [β(SE) = −0.3 (0.04), P = 0.02]. Additionally, we report for the first-time reductions in specific ceramide ratios that have been shown to predict CVD mortality and major adverse cardiovascular events such as d18:1/16:0, d18:0/24:0, and d18:1/24:1 which were associated with the reduction in the abundance in Colinsella and increases in Bifidobacteriuim and Coprococcus 3 and SCFAs (all P < 0.05). Conclusion: Overall, these findings support the potential of using simple dietary interventions to alter validated biomarkers linked to cardiovascular risk via the gut microbiome composition and its metabolic functions. |
format | Online Article Text |
id | pubmed-8319029 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83190292021-07-30 Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites Vijay, Amrita Astbury, Stuart Panayiotis, Louca Marques, Francine Z. Spector, Tim D. Menni, Cristina Valdes, Ana M. Front Cardiovasc Med Cardiovascular Medicine Aims: The current study investigates the role of diet in mediating the gut microbiome-cardiovascular association which has not yet been explored in humans. Methods and Results: Using a two-arm dietary intervention study in healthy participants (N = 70), we assessed the effects of omega-3 and fibre supplementation on gut microbiome composition and short-chain fatty acid (SCFA) production. We then investigated how changes in gut microbiome composition correlated with changes in traditional cardiovascular risk factors (cholesterol, triglycerides, blood pressure), cytokines, and novel validated markers such as GlycA and ceramides, previously linked to CVD incidence and mortality. Both interventions resulted in significant drops in blood pressure, cholesterol, proinflammatory cytokines, GlycA and ceramides (all P < 0.05). Decreases in the atherogenic low-density lipoprotein triglyceride fraction, in total serum cholesterol were correlated with increases in butyric acid-production [β(SE) = −0.58 (0.06), P < 0.001; −0.53 (0.04), P < 0.001] and nominally associated with increases in some butyrogenic bacteria. Drops in GlycA were linked to increases in Bifidobacterium [β(SE) = −0.32 (0.04), P = 0.02] and other SCFAs including acetic acid [β(SE) = −0.28 (0.04), P = 0.02] and propionic acid [β(SE) = −0.3 (0.04), P = 0.02]. Additionally, we report for the first-time reductions in specific ceramide ratios that have been shown to predict CVD mortality and major adverse cardiovascular events such as d18:1/16:0, d18:0/24:0, and d18:1/24:1 which were associated with the reduction in the abundance in Colinsella and increases in Bifidobacteriuim and Coprococcus 3 and SCFAs (all P < 0.05). Conclusion: Overall, these findings support the potential of using simple dietary interventions to alter validated biomarkers linked to cardiovascular risk via the gut microbiome composition and its metabolic functions. Frontiers Media S.A. 2021-07-14 /pmc/articles/PMC8319029/ /pubmed/34336953 http://dx.doi.org/10.3389/fcvm.2021.691564 Text en Copyright © 2021 Vijay, Astbury, Panayiotis, Marques, Spector, Menni and Valdes. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Vijay, Amrita Astbury, Stuart Panayiotis, Louca Marques, Francine Z. Spector, Tim D. Menni, Cristina Valdes, Ana M. Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites |
title | Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites |
title_full | Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites |
title_fullStr | Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites |
title_full_unstemmed | Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites |
title_short | Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites |
title_sort | dietary interventions reduce traditional and novel cardiovascular risk markers by altering the gut microbiome and their metabolites |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319029/ https://www.ncbi.nlm.nih.gov/pubmed/34336953 http://dx.doi.org/10.3389/fcvm.2021.691564 |
work_keys_str_mv | AT vijayamrita dietaryinterventionsreducetraditionalandnovelcardiovascularriskmarkersbyalteringthegutmicrobiomeandtheirmetabolites AT astburystuart dietaryinterventionsreducetraditionalandnovelcardiovascularriskmarkersbyalteringthegutmicrobiomeandtheirmetabolites AT panayiotislouca dietaryinterventionsreducetraditionalandnovelcardiovascularriskmarkersbyalteringthegutmicrobiomeandtheirmetabolites AT marquesfrancinez dietaryinterventionsreducetraditionalandnovelcardiovascularriskmarkersbyalteringthegutmicrobiomeandtheirmetabolites AT spectortimd dietaryinterventionsreducetraditionalandnovelcardiovascularriskmarkersbyalteringthegutmicrobiomeandtheirmetabolites AT mennicristina dietaryinterventionsreducetraditionalandnovelcardiovascularriskmarkersbyalteringthegutmicrobiomeandtheirmetabolites AT valdesanam dietaryinterventionsreducetraditionalandnovelcardiovascularriskmarkersbyalteringthegutmicrobiomeandtheirmetabolites |